DCM
VRTX icon

Driehaus Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Driehaus Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-677
Closed -$301K – 513
2025
Q2 		$301K Sell
677
-431
-39% -$199K ﹤0.01% 399
2025
Q1 		$537K Sell
1,108
-14
-1% -$6.52K 0.01% 368
2024
Q4 		$452K Sell
1,122
-47
-4% -$21.8K ﹤0.01% 359
2024
Q3 		$544K Hold
1,169
– – ﹤0.01% 341
2024
Q2 		$548K Buy
1,169
+235
+25% +$102K 0.01% 329
2024
Q1 		$390K Sell
934
-1,195
-56% -$505K ﹤0.01% 356
2023
Q4 		$866K Buy
2,129
+441
+26% +$163K 0.01% 321
2023
Q3 		$587K Hold
1,688
– – 0.01% 347
2023
Q2 		$594K Buy
+1,688
New +$569K 0.01% 335
2018
Q1 		– Sell
-2,088
Closed -$313K – 601
2017
Q4 		$313K Sell
2,088
-475
-19% -$70.3K 0.01% 462
2017
Q3 		$390K Buy
+2,563
New +$386K 0.02% 423
2015
Q4 		– Sell
-4,139
Closed -$431K – 641
2015
Q3 		$431K Buy
+4,139
New +$532K 0.02% 440

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Driehaus Capital Management's VRTX Position: Q3 2025 in Review

Driehaus Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 677 shares — an estimated $301K sold.

Driehaus Capital Management first reported a position in VRTX in Q3 2015 and held it in 12 quarters. The position peaked at $866K in Q4 2023. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Driehaus Capital Management reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Driehaus Capital Management sold 677 Vertex Pharmaceuticals shares in Q3 2025, an estimated $301K.
  • Driehaus Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2015 and held it in 12 quarters.
  • Driehaus Capital Management's Vertex Pharmaceuticals position peaked at $866K in Q4 2023.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Driehaus Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.